Brazil opened a reciprocity process against the United States on August 14, a preliminary step over US tariffs that begins with diplomatic consultations rather than immediate counter-measures [1]. The Brazilian government called the tariffs "unjustified and arbitrary" and said it would "continue to defend its position in all appropriate forums" [1].
The tariffs at issue came in two layers. Washington imposed a 25 percent surcharge on Brazilian exports including sugar, clothing, paper and steel, and added a further 12.5 percent tariff based on allegations concerning Brazil's enforcement of forced-labor prohibitions [1].
Brazil's response runs through its Reciprocity Law, which President Luiz Inacio Lula da Silva has committed to invoking to shield the Brazilian economy [1]. The law's menu is broad. Al Jazeera reported that Brazil's measures could include imposing taxes or fees, eliminating exemptions, reducing import tariffs, or restricting American goods and services [1]. Citing a Reuters source, the report said "further measures could go beyond tariffs, for example by suspending pharmaceutical and agricultural patents" [1].
That patent option is what separates this from an ordinary tariff exchange. Suspending patents held by US pharmaceutical and agricultural firms would strike at intellectual-property rights, not just goods crossing a border, and it is the reason the reciprocity filing carries weight beyond its opening-day formality.
For now the process is early. Lula has committed to invoking the law without yet deciding on any specific retaliation, and the August 14 move begins with consultations [1].
The trade balance frames what is at stake for each side. The United States maintains a trade surplus with Brazil, having exported $26.5 billion to it while importing $17 billion in 2026 so far, according to US Census Bureau data cited by Al Jazeera [1]. That surplus is what Brasilia is signaling it can reach, through the goods, services and patents its law lets it target.
